Intracellular Antiviral Activity of Low-Dose Ritonavir in Boosted Protease Inhibitor Regimens

Protease inhibitors are largely used for the treatment of HIV infection in combination with other antiretroviral drugs. Their improved pharmacokinetic profiles can be achieved through the concomitant administration of low doses of ritonavir (RTV), a protease inhibitor currently used as a booster, in...

詳細記述

保存先:
書誌詳細
主要な著者: De Nicolò, Amedeo, Simiele, Marco, Calcagno, Andrea, Mohamed Abdi, Adnan, Bonora, Stefano, Di Perri, Giovanni, D'Avolio, Antonio
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2014
主題:
Antiviral Agents
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068548/
https://ncbi.nlm.nih.gov/pubmed/24798279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00104-14
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料